ESTIMATED
05/11/2020
05/11/2020
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | $1.57 | $1.57 | $1.57 |
Q2 2024 | 0 | $1.34 | $1.34 | $1.34 |
Q3 2024 | 0 | $1.54 | $1.54 | $1.54 |
XBiotech Inc. last posted its earnings results on Monday, May 11th, 2020. The company reported $-0.00039 earnings per share for the quarter, missing analysts' consensus estimates of $0.06 by $0.06039. The company had revenue of 0 for the quarter and had revenue of 0 for the year. XBiotech Inc. has generated $-1 earnings per share over the last year ($-0.81 diluted earnings per share) and currently has a price-to-earnings ratio of -5.64. XBiotech Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 9th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/10/2024 | Q1 2024 | -$0.33 | $0 | $0 | 03/15/2024 | Q4 2023 | -$0.15 | $2.62 M | $2.62 M | 11/09/2023 | Q3 2023 | -$0.24 | $0 | 08/11/2023 | Q2 2023 | -$0.29 | $0 | 05/10/2023 | Q1 2023 | -$0.13 | $0 | 03/15/2023 | Q4 2022 | -$0.11 | $300,000 | 11/09/2022 | Q3 2022 | -$0.42 | $1.68 M | 08/09/2022 | Q2 2022 | -$0.38 | $1.53 M | 05/10/2022 | Q1 2022 | -$0.18 | $500,000 | 03/15/2022 | Q4 2021 | -$0.21 | $7.00 M | $4.50 M | 11/09/2021 | Q3 2021 | -$0.11 | $7.00 M | $4.52 M | 08/09/2021 | Q2 2021 | -$0.17 | $7.00 M | $4.53 M | 05/10/2021 | Q1 2021 | -$0.09 | $4.85 M | 03/16/2021 | Q4 2020 | -$0.06 | $7.00 M | $5.27 M | 11/09/2020 | Q3 2020 | -$0.09 | $7.00 M | $10.55 M | 08/10/2020 | Q2 2020 | -$0.24 | $7.00 M | $15.50 M | 05/11/2020 | Q1 2020 | $0.06 | -$0.00 | -0.06 | $12.68 M | 03/16/2020 | Q4 2019 | -$0.15 | $18.98 | 19.13 | $0 | 11/12/2019 | Q3 2019 | -$0.15 | -$0.15 | 0 | $0 | 08/09/2019 | Q2 2019 | -$0.15 | -$0.16 | -0.01 | $0 |
---|
A. XBiotech Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 9th, 2024 based off last year's report dates.
A. The conference call for XBiotech Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for XBiotech Inc.'s latest earnings report can be read online.
A. XBiotech Inc. (NASDAQ:XBIT) has a recorded net income of $0. XBiotech Inc. has generated $-0.81 earnings per share over the last four quarters.
A. XBiotech Inc. (NASDAQ:XBIT) has a price-to-earnings ratio of -5.64 and price/earnings-to-growth ratio is -0.23.